ALISON L. HANNAH Insider Trading $NEO NEOGENOMICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ALISON L. HANNAH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ALISON L. HANNAH. ALISON L. HANNAH is Director in NEOGENOMICS INC ($NEO) and Chief Medical Officer in CytomX Therapeutics, Inc. ($CTMX).
ALISON L. HANNAH in NEOGENOMICS INC
Industry: SERVICES-TESTING LABORATORIES [8734]
Position of ALISON L. HANNAH: Director
Holdings: 88,796 shares
Current Value: $713,920
Latest Transaction: Aug 10 2020
$NEO Market Capitalization: $625.74M
$NEO Previous Close: $8.04
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ALISON L. HANNAH in NEOGENOMICS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10 2020 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | M | 7.27 | 10,000 | 72,700 | 0 | |
| Aug 10 2020 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Buy | M | 7.27 | 10,000 | 72,700 | 88,796 | 78.8 K to 88.8 K (+12.69 %) |
| Jun 01 2020 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 28.54 | 3,448 | 98,406 | 3,448 | |
| Jun 01 2020 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Grant | A | 0.00 | 2,698 | 0 | 78,796 | 76.1 K to 78.8 K (+3.55 %) |
| Sep 11 2019 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | M | 9.11 | 8,333 | 75,914 | 0 | |
| Sep 11 2019 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | M | 6.66 | 3,333 | 22,198 | 0 | |
| Sep 11 2019 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Buy | M | 9.11 | 8,333 | 75,914 | 76,098 | 67.8 K to 76.1 K (+12.30 %) |
| Sep 11 2019 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Buy | M | 6.66 | 3,333 | 22,198 | 67,765 | 64.4 K to 67.8 K (+5.17 %) |
| Jun 10 2019 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 22.52 | 4,269 | 96,138 | 4,269 | |
| Jun 10 2019 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 22.52 | 4,269 | 96,138 | 4,269 | |
| Jun 10 2019 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Grant | A | 0.00 | 3,419 | 0 | 64,432 | 61 K to 64.4 K (+5.60 %) |
| Jun 10 2019 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Grant | A | 0.00 | 3,419 | 0 | 64,432 | 61 K to 64.4 K (+5.60 %) |
| Jun 05 2018 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 11.60 | 3,017 | 34,997 | 3,017 | |
| Jun 05 2018 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Grant | A | 0.00 | 15,564 | 0 | 61,013 | 45.4 K to 61 K (+34.24 %) |
| Jul 31 2017 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Buy | P | 9.19 | 20,000 | 183,800 | 38,782 | 18.8 K to 38.8 K (+106.48 %) |
| May 30 2017 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 0.00 | 8,667 | 0 | 8,667 | |
| May 30 2017 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 7.27 | 10,000 | 72,700 | 10,000 | |
| May 30 2017 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | C | 0.00 | 5,072 | 0 | 0 | |
| May 30 2017 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | C | 0.00 | 2,150 | 0 | 0 | |
| May 30 2017 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Buy | M | 0.00 | 7,222 | 0 | 18,782 | 11.6 K to 18.8 K (+62.47 %) |
| Aug 01 2016 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 9.11 | 8,333 | 75,914 | 25,555 | |
| Aug 01 2016 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 0.00 | 5,072 | 0 | 7,222 | |
| May 04 2016 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Grant | A | 7.15 | 2,150 | 15,373 | 13,710 | 11.6 K to 13.7 K (+18.60 %) |
| Mar 04 2016 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Buy | P | 6.90 | 10,000 | 69,000 | 11,560 | 1.6 K to 11.6 K (+641.03 %) |
| Jul 16 2015 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 6.66 | 10,000 | 66,600 | 10,000 |
Page: 1